122 related articles for article (PubMed ID: 16679757)
1. Accurate measurement and clinical significance of urinary transforming growth factor-beta1.
Tsakas S; Goumenos DS
Am J Nephrol; 2006; 26(2):186-93. PubMed ID: 16679757
[TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factor-beta 1 in various types of nephropathy.
De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
[TBL] [Abstract][Full Text] [Related]
4. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
BMC Nephrol; 2005 Dec; 6():16. PubMed ID: 16367998
[TBL] [Abstract][Full Text] [Related]
5. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
6. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
7. Urinary transforming growth factor-beta1 in feline chronic renal failure.
Arata S; Ohmi A; Mizukoshi F; Baba K; Ohno K; Setoguchi A; Tsujimoto H
J Vet Med Sci; 2005 Dec; 67(12):1253-5. PubMed ID: 16397385
[TBL] [Abstract][Full Text] [Related]
8. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
Boratyńska M
Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
[TBL] [Abstract][Full Text] [Related]
9. [TGF-beta1 in allograft and long-term renal function].
Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
[TBL] [Abstract][Full Text] [Related]
10. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.
Shin GT; Kim SJ; Ma KA; Kim HS; Kim D
Am J Kidney Dis; 2000 Nov; 36(5):894-902. PubMed ID: 11054345
[TBL] [Abstract][Full Text] [Related]
12. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
13. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
[TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins.
Douthwaite JA; Johnson TS; Haylor JL; Watson P; El Nahas AM
J Am Soc Nephrol; 1999 Oct; 10(10):2109-19. PubMed ID: 10505687
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
Krag S; Nyengaard JR; Wogensen L
Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation.
Birch Nielsen C; Krag S; ØSterby R; Flyvbjerg A; Nyengaard J; Forman A; Wogensen L
Virchows Arch; 2004 Jun; 444(6):561-6. PubMed ID: 15107991
[TBL] [Abstract][Full Text] [Related]
18. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction.
Liatsikos EN; Dinlenc CZ; Bernardo NO; Kapoor R; Jabbour ME; Smith AD; Kushner L
J Endourol; 2001 Aug; 15(6):567-70. PubMed ID: 11552777
[TBL] [Abstract][Full Text] [Related]
19. Urinary transforming growth factor-beta in patients with glomerular diseases.
Murakami K; Takemura T; Hino S; Yoshioka K
Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
[TBL] [Abstract][Full Text] [Related]
20. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
